Nina Capital Holdings Inc. Acquires 12,500 Shares of PetMed Express, Inc. (NASDAQ:PETS) Stock

PetMed Express, Inc. (NASDAQ:PETS) major shareholder Nina Capital Holdings Inc. purchased 12,500 shares of the stock in a transaction on Monday, September 9th. The shares were acquired at an average cost of $3.34 per share, with a total value of $41,750.00. Following the transaction, the insider now directly owns 2,078,000 shares in the company, valued at $6,940,520. The trade was a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

PetMed Express Trading Up 0.3 %

Shares of PETS stock traded up $0.01 during midday trading on Friday, reaching $3.98. 84,341 shares of the stock were exchanged, compared to its average volume of 340,601. PetMed Express, Inc. has a 1 year low of $2.90 and a 1 year high of $10.53. The company’s 50 day moving average is $3.49 and its two-hundred day moving average is $3.91. The firm has a market cap of $81.99 million, a PE ratio of -23.41 and a beta of 0.71.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Tuesday, August 6th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.30. PetMed Express had a negative return on equity of 3.44% and a negative net margin of 1.24%. The firm had revenue of $67.95 million for the quarter, compared to the consensus estimate of $77.52 million. As a group, equities analysts expect that PetMed Express, Inc. will post 0.08 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Lake Street Capital reaffirmed a “hold” rating and set a $3.50 price target (down previously from $7.00) on shares of PetMed Express in a research report on Wednesday, August 7th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Point72 DIFC Ltd purchased a new position in shares of PetMed Express during the 2nd quarter worth approximately $34,000. Oak Thistle LLC purchased a new position in shares of PetMed Express during the 1st quarter worth approximately $50,000. Marshall Wace LLP purchased a new stake in shares of PetMed Express in the 2nd quarter worth approximately $46,000. SG Americas Securities LLC purchased a new stake in shares of PetMed Express in the 2nd quarter worth approximately $46,000. Finally, Pinnacle Wealth Planning Services Inc. purchased a new stake in shares of PetMed Express in the 1st quarter worth approximately $61,000. Hedge funds and other institutional investors own 73.33% of the company’s stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.